Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Inflammatory Bowel Diseases|May 26, 2018
BCL2 Regulates Differentiation of Intestinal FibroblastsBruce Weder, Céline Mamie, Gerhard Rogler, et al.
Oxford Medical Case Reports|May 20, 2015
Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junctionMinmin Li, David Chan, Bob T Li, et al.
Plos One|March 27, 2014
Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulationMaria Tsoli, Martina Schweiger, Anne S Vanniasinghe, et al.
Integrative Cancer Therapies|July 1, 2011
A critical review of the effects of medical Qigong on quality of life, immune function, and survival in cancer patientsByeongsang Oh, Phyllis Butow, Barbara Mullan, et al.
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|September 24, 2016
Factors affecting whether or not cancer patients consider using acupunctureByeongsang Oh, Thomas Eade, Andrew Kneebone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 2012
Health-related quality of life and inflammatory markers in malignant pleural mesotheliomaSteven C Kao, Janette Vardy, Rozelle Harvie, et al.
Clinical Colorectal Cancer|August 8, 2007
Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacyStephen Clarke, David Goldstein, Paul Mitchell, et al.
Veterinary Surgery : VS|July 30, 2013
Precision of a novel computed tomographic method for quantification of femoral varus in dogs and an assessment of the effect of femoral malpositioningBill Oxley, Toby J Gemmill, Jonathan Pink, et al.
The American Journal of Managed Care|November 14, 2022
Predicting drug-drug and drug-gene interactions in a community pharmacy populationDaniel Dowd, Gabriela Williams, Daniel VanDorn, et al.
Asia-Pacific Journal of Clinical Oncology|November 11, 2014
Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: an evidence-based benchmark for cancer careSteven Chuan-Hao Kao, Nico van Zandwijk, Stephen Clarke, et al.
Pageof 20